Mosseri Marlio Charles (CIK 1806384) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy NVCT (50,000 shares), Buy NVCT (46,900 shares), Buy NVCT (35,034 shares), Buy NVCT (72,836 shares), Buy NVCT (5,603 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 50,000 | $916,000 |
| 2025-10-29 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 46,900 | $284,214 |
| 2025-10-29 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 35,034 | $215,459 |
| 2025-10-29 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 72,836 | $457,410 |
| 2025-06-24 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 5,603 | $44,768 |
| 2025-06-20 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 5,399 | $43,786 |
| 2025-06-20 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 28,043 | $225,746 |
| 2025-05-13 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 21,167 | $171,664 |
| 2025-05-12 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 100 | $899 |
| 2025-05-12 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 100 | $871 |
| 2025-05-12 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 2,400 | $21,528 |
| 2025-05-12 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 9,850 | $88,158 |
| 2025-05-12 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 9,817 | $87,371 |
| 2025-05-12 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 5,395 | $48,447 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 2,340 | $19,656 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 10,104 | $87,299 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 2,703 | $22,705 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 9,614 | $83,065 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 50 | $432 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 100 | $865 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 100 | $865 |
| 2025-05-09 | Nuvectis Pharma, Inc. (NVCT) | 10% Owner | Buy | 2,400 | $20,760 |
来源：SEC Form 4 申报文件 · 截至 2026-07-01